Byetta and Januvia are two drugs used to treat Type 2 diabetes. The FDA approved Byetta in 2005 and Januvia in 2006. These drugs have been prescribed to millions of people in the United States. Since approving the medications, the FDA has issued several warnings about links between Byetta and Januvia to complications related to pancreatic diseases. Recent studies have linked these two drugs to acute pancreatitis and pancreatic cancer. We are currently investigating claims of pancreatic cancer.